These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33847414)

  • 41. Tuberculosis Infection in Children and Adolescents: Testing and Treatment.
    Nolt D; Starke JR
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34851422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S
    Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contact investigation in healthcare personnel exposed to pediatric patients with pulmonary tuberculosis at the pediatric ward, Vajira hospital, Thailand.
    Kanjanaphan T
    Indian J Tuberc; 2023; 70 Suppl 1():S72-S75. PubMed ID: 38110264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculin skin test versus interferon-gamma release assay in refugee children: A retrospective cohort study.
    Elliot C; Marais B; Williams P; Joshua P; Towle S; Hart G; Zwi K
    J Paediatr Child Health; 2018 Aug; 54(8):834-839. PubMed ID: 29442397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].
    Komukai J; Matsumoto K; Tomihara A; Miyake Y; Tatsumi T; Arima K; Danno K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):847-56. PubMed ID: 22250463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.
    Weinberg A; Aaron L; Montepiedra G; Sterling TR; Browning R; Mmbaga B; Vhembo T; Naik S; Kabugho E; Masheto G; Pahwa S; Mathad JS; LaCourse SM; McCarthy K; Bradford S; Theron G; Costello D; Zimmer B; Pierre MF; Gausi K; Denti P; Haas DW; Gupta A;
    Clin Infect Dis; 2021 Nov; 73(9):e3555-e3562. PubMed ID: 32720695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
    Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P; Doherty TM; Hailu A; Aseffa A
    BMC Res Notes; 2012 Aug; 5():415. PubMed ID: 22870897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation.
    Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti-TNF agents for rheumatologic diseases.
    Kilinc AA; Onal P; Oztosun B; Yildiz M; Adrovic A; Sahin S; Barut K; Cokugras H; Kasapcopur O
    Pediatr Pulmonol; 2020 Oct; 55(10):2689-2696. PubMed ID: 32776324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?
    Akyuz F; Cavus B; Iliaz R; Soyer OM; Ormeci A; Evirgen S; Onder S; Koksalan K; Keskin M; Karaca C; Demir K; Gulluoglu M; Cagatay T; Besisik F; Kaymakoglu S
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):777-780. PubMed ID: 30964811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
    BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimizing the management of children with latent tuberculosis infection.
    Venturini E; Tersigni C; Chiappini E; de Martino M; Galli L
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):341-349. PubMed ID: 28074660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study.
    Gatechompol S; Harnpariphan W; Supanan R; Suwanpimolkul G; Sophonphan J; Ubolyam S; Kerr SJ; Avihingsanon A; Kawkitinarong K
    BMC Public Health; 2021 Jun; 21(1):1206. PubMed ID: 34162348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
    Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
    BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
    Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of screening tests for diagnosis of latent tuberculosis infection in children.
    Böncüoğlu E; Kıymet E; Şahinkaya Ş; Akaslan Kara A; Çağlar İ; Arıkan KÖ; Gülfidan G; Bayram N; Devrim İ
    Pediatr Pulmonol; 2021 May; 56(5):1114-1120. PubMed ID: 33200565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.